Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gamze Gokturk Ozcan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Pathology Informatics|November 11, 2021
FlexTileSource: An OpenSeadragon Extension for Efficient Whole-Slide Image VisualizationPeter J Schüffler, Gamze Gokturk Ozcan, Hikmat Al-Ahmadie, et al.
Urologic Oncology|May 23, 2025
Genomic profiling of urological malignancies using tissue-based next generation sequencingZainab I Alruwaii, Gamze Gokturk Ozcan, Oudai Hassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder CancerAndrew B Katims, Charlie White, Syed Muneeb Alam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
European Urology|April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial CarcinomaCarissa E Chu, Ziyu Chen, Karissa Whiting, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Pathology Informatics|November 11, 2021
FlexTileSource: An OpenSeadragon Extension for Efficient Whole-Slide Image VisualizationPeter J Schüffler, Gamze Gokturk Ozcan, Hikmat Al-Ahmadie, et al.
Urologic Oncology|May 23, 2025
Genomic profiling of urological malignancies using tissue-based next generation sequencingZainab I Alruwaii, Gamze Gokturk Ozcan, Oudai Hassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Urinary Biomarkers Objectively Measure Minimal Residual Disease in Non-Muscle-Invasive Bladder CancerAndrew B Katims, Charlie White, Syed Muneeb Alam, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2024
Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic ImplicationsDilara Akbulut, Karissa Whiting, Min-Yuen Teo, et al.
Nature Communications|September 10, 2025
Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancerKevin Chang, Henry M Delavan, Elizabeth Yip, et al.
European Urology|April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial CarcinomaCarissa E Chu, Ziyu Chen, Karissa Whiting, et al.
European Urology|November 16, 2024
Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial CarcinomaKwanghee Kim, Syed M Alam, Fengshen Kuo, et al.
Pageof 1